NewsBot
Registered
- 6 Aug 2002
- 2
- 0
Natera Inc. NTRA said Japan's Ministry of Health, Labour and Welfare approved its Signatera molecular residual disease (MRD) test for patients with colorectal cancer in the adjuvant setting, making it ...
Continue reading...
Continue reading...